| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| 07:30 | Glaston Oyj: Glaston's Financial Statement Bulletin January 1 - December 31, 2025: Soft market continued, profitability supported by productivity improvements. | 41 | GLASTON CORPORATION FINANCIAL STATEMENT BULLETIN 13 FEBRUARY 2026 AT 8.30
This release is a summary of Glaston Corporation's financial statement bulletin for 2025. The complete report is attached... ► Artikel lesen | ||
| 07:30 | Acconeer AB: Year-end report January 1 - December 31 2025 | 58 | In the fourth quarter of 2025, Acconeer's net sales amounted to SEK 17.2 million, an increase of 67% compared to the same period in 2024 and the second consecutive quarter of record sales. For the full... ► Artikel lesen | ||
| 07:30 | SenzaGen AB: SenzaGen's Year-End Report 2025 | SenzaGen closes the year with continued strong GARD sales | 56 | Message from the CEO
"As previously stated in the half-year report, 2025 performance was stronger in the second half of the year. GARD® continued to strengthen its market position with positive sales... ► Artikel lesen | ||
| 07:30 | Apetit Plc: Apetit Plc's Financial Statements Release 1 January - 31 December 2025: Operating result increased due to the non-recurring non-cash accounting impact of an acquisition | 28 | 13.2.2026 08:30:00 EET | Apetit Oyj |
Financial Statement Release
Apetit Plc's Financial Statements Release 1 January - 31 December 2025: Operating result increased due to the non-recurring non-cash... ► Artikel lesen | ||
| 07:30 | Posti Group Oyj: Profitability in Q4 improved driven by strong operational execution during peak season | 51 | Posti Group Corporation Stock Exchange Release February 13, 2025, at 8.30 a.m. EETFinancial highlights in October-December 2025
Net sales decreased by 3.3% to EUR 390.4 (403.6) million.
Adjusted... ► Artikel lesen | ||
| 07:30 | Nosa Plugs AB: Nosa Plugs AB Year End Report 2025 | 47 | CEO statement
We conclude 2025 with solid sales growth, both organically and in the acquired business. Revenue for the quarter amounts to approximately 11.2 MSEK and we also reach our strategically... ► Artikel lesen | ||
| 07:30 | NCAB Group AB: NCAB Year-end Report 2025 | 64 | OCTOBER-DECEMBER 2025
> Net sales increased 9% to SEK 901.9 million (830.3). In USD, net sales increased by 25%. For comparable units, net sales increased by 5% in SEK and by 21% in USD.> Order intake... ► Artikel lesen | ||
| 07:30 | BeammWave AB: BeammWave publishes Year-End Report for 2025 | 52 | Closing 2025 with Operational Precision
BeammWave AB's Year-End report for 2025 is now available on the Company's website beammwave.com/investors/financial-reports/.We are entering 2026 with a clear... ► Artikel lesen | ||
| 07:30 | HKFoods Plc: HKFoods Plc's Financial Statements Bulletin 2025: Good profitability development continued in 2025 | 49 | HKFoods Plc, Financial Statements Bulletin, 13 February 2026 at 8:30 a.m. EET
HKFoods' Financial Statements Bulletin 1 January-31 December 2025
October-December 2025
HKFoods' comparable EBIT from... ► Artikel lesen | ||
| 07:30 | Huhtamäki Oyj: Huhtamäki Oyj's Results January 1-December 31, 2025: Solid performance despite adverse currency impacts | 84 | HUHTAMÄKI OYJ FINANCIAL STATEMENT RELEASE 13.2.2026 AT 8:30 EET Huhtamäki Oyj's Results January 1-December 31, 2025: Solid performance despite adverse currency impacts Q4 2025 in brief Net sales decreased... ► Artikel lesen | ||
| 07:22 | Novartis Pharma AG: Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy | 603 |
In ALIGN study, Vanrafia (atrasentan) showed positive difference
in eGFR change from baseline vs. placebo at Week 136, 4 weeks after study treatment ended1Results favored Vanrafia across multiple... ► Artikel lesen | ||
| 07:13 | CM.com N.V.: CM.com delivers record EBITDA in 2025 | 93 | Breda, the Netherlands, February 13, 2026 - Today, CM.com has published its 2025 fourth-quarter and full-year results
Financial Highlights
• Record 2025 EBITDA of € 18.4 million, up 12% year-on-year
•... ► Artikel lesen | ||
| 07:10 | Norsk Hydro: Key information related to proposed cash dividend | 208 | The Board of Directors of Norsk Hydro ASA have decided to propose to the General Meeting a dividend of NOK 3.0 per share on the basis of the company's financial statements for the financial year 2025.... ► Artikel lesen | ||
| 07:10 | Norsk Hydro: Solid upstream performance driving strong cash flow generation | 340 | Hydro's adjusted EBITDA for the fourth quarter of 2025 was NOK 5,587 million, down from NOK 7,701 million in the same quarter last year. The results decreased from lower realized alumina prices and... ► Artikel lesen | ||
| 07:06 | Capgemini Services SAS: Full-year 2025 results | 417 | Media relations:Victoire GruxTel.: +33 6 04 52 16 55victoire.grux@capgemini.com Investor relations:Vincent BiraudTel.: +33 1 47 54 50 87vincent.biraud@capgemini.com Full-year 2025 results Revenues... ► Artikel lesen | ||
| 07:06 | Coop Pank AS results for January 2026 | 57 | Coop Pank's financial results in January 2026: In January, number of the bank's clients increased by 1,400 and number of active clients decreased by 500. By the end of the month number of clients... ► Artikel lesen | ||
| 07:00 | Loihde Oyj: Loihde Plc's financial statements release 1 January-31 December 2025: Profitable growth: In Q4, adjusted EBITDA improved by 39% to 13% of revenue | 23 | 13.2.2026 08:00:01 EET | Loihde Oyj |
Financial statement release
Loihde Plc Company announcement 13 February 2026 at 8:00 a.m. EET (unaudited)
Loihde Plc's financial statements release 1 January-31... ► Artikel lesen | ||
| 07:00 | Karnell Group AB: Karnell Year-end report January - December 2025 | 38 | "The fourth quarter demonstrates the strength of Karnell's business model with organic growth, improved EBITA margin and strong cash flow, and we enter 2026 with improved momentum, a stable financial... ► Artikel lesen | ||
| 07:00 | Diös Fastigheter AB: Diös Fastigheter's Year-end Report 2025 | 53 | The year ends with a strong performance. Property management income increased by 10 per cent during the year, and profitable investments drove positive unrealised changes in value. This confirms the... ► Artikel lesen | ||
| 07:00 | Lyko Group AB: Strong Growth, Profitability Below Our Expectations | 361 | The fourth quarter delivered strong growth, with net sales increasing 17% to SEK 1,278m. For the full year, we reached SEK 3,963m, up 11% compared with 2024. We welcomed more than 350,000 new customers... ► Artikel lesen | ||
| 07:00 | Fingerprint Cards AB: Fingerprint Cards AB (publ) publishes year-end report for January - December 2025 | 180 | The report is available as an online version and as a PDF."Growing AllKey momentum and improved earnings and cash flow mark an important step as we focus the company on scalable, profitable growth."... ► Artikel lesen | ||
| 07:00 | Stockwik Förvaltning AB: Stockwik publishes Year-End Report January 1 - December 31, 2025 | 37 | "Continued organic growth, new long-term financing secured, and expected first acquisition since 2022!" Urban Lindskog, CEO and Group President
OCTOBER 1 - DECEMBER 31 2025· Net sales MSEK 274.9 (253.8).... ► Artikel lesen | ||
| 07:00 | Kesko Oyj: Kesko's sales in January | 49 | KESKO INVESTOR NEWS 13.2.2026 AT 8.00
Kesko's sales increased by 3.8% in January, or by 0.8% in comparable terms.
"Kesko's sales increased by 3.8% in January, and sales grew in all divisions. In the... ► Artikel lesen | ||
| 06:58 | DDPAI Technology Co., Ltd: DDPAI Unveils N5 Pro: A Fusion of Minimalist Esthetics and 4K Flagship Performance | 716 | "Smart Vision, Compact Power" - The new dashcam features 4K+2K dual recording, built-in eMMC storage, and advanced radar parking monitoring.SHENZHEN, China, Feb. 13, 2026 (GLOBE NEWSWIRE) -- DDPAI,... ► Artikel lesen | ||
| 04:34 | OKYO Pharma Announces Pricing of $20 Million Public Offering of Ordinary Shares | 308 | LONDON and NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic... ► Artikel lesen |